Research Information
CJC-1295 without DAC
GH Peptides · Synthetic GHRH analogue
Short research overview
CJC-1295 without DAC is catalogued as a synthetic analogue of growth-hormone-releasing hormone. The “without DAC” designation is part of this compound’s identity and distinguishes this entry from CJC formats that include a drug-affinity-complex modification; it is not interchangeable with the separate Tesamorelin entry.
View the CJC-1295 without DAC product page·Compare CJC-1295 without DAC and TesamorelinHow it is being studied
The supported research context focuses on agonist activity at the GHRH receptor and downstream cyclic-AMP signalling. This places the compound in receptor pharmacology and pituitary-signalling research while keeping the focus on the specific CJC-1295 without DAC form.
Areas of Research
- CJC-1295 without DAC receptor pharmacology
- GHRH-linked cyclic-AMP signalling
- Pituitary response models for the non-DAC form
Current Research Status
Research reference only. This entry does not represent an approved therapeutic use or medical recommendation.
Available Strength
10mg
Scientific References
CJC-1295 without DAC literature index
PubMed · National Library of Medicine
CJC-1295 without DAC 10mg analytical certificate
PEPY verification archive
For Research Purposes Only
This information is provided as a scientific reference and does not include medical, dosing, administration or human-use guidance.